Legal Opinion
Spectrum Pharmaceuticals, Inc. v. Sandoz Inc.
Court of Appeals for the Federal Circuit
Decided October 2, 2015No. 2015-1407PublishedCited by 32 opinions
1Opinion of the Court
LOURIE, Circuit Judge.
Spectrum Pharmaceuticals, Inc. (“Spectrum”) appeals from the decisions of the. United States District Court for the District of Nevada holding claims 1-2 of U.S. Patent 6,500,829 (“the '829 patent”) invalid as obvious, and finding claims 5-9 of the '829 patent not infringed by the submission of an Abbreviated New Drug Application (“ANDA”) by Sandoz Inc. (“Sandoz”). Spectrum Pharm., Inc. v. Sandoz Inc., No. 2:12-cv-00111, 2015 WL 794674 (D.Nev. Feb. 25, 2015) (“Trial Order”); Spectrum Pharm., Inc. v. Sandoz Inc., No. 2:12-cv-00111, 2014 WL 7368845 (D.Nev. Dec. 29, 2014)…
2Cases cited25 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Warner-Jenkinson Co. v. Hilton Davis Chemical Co.Supreme Court of the United States · 1997
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
20 more not listed; retrieve them via the Exa API.
3Cited by32 opinions
- Mylan Institutional LLC v. Aurobindo Pharma Ltd.Court of Appeals for the Federal Circuit · 2017
- Amgen Inc. v. Coherus Biosciences Inc.Court of Appeals for the Federal Circuit · 2019
- Celgene Corporation v. PeterCourt of Appeals for the Federal Circuit · 2019
- Ajinomoto Co. v. Int'l Trade Comm'nCourt of Appeals for the Federal Circuit · 2019
- Vlsi Technology LLC v. Intel CorporationCourt of Appeals for the Federal Circuit · 2023
27 more not listed; retrieve them via the Exa API.